We are live on ! Find out more

37 hedge funds and large institutions have $35.9M invested in Evotec in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more capital inflows, than outflows

Capital inflows: $2.08M | Capital outflows: $1.24M

38% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 8

0.07% more ownership

Funds ownership: 2.72% → 2.78% (+0.07%)

0% more funds holding

Funds holding: 37 → 37 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 8

Holders
37
Holders Change
–
Holders Change %
0%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
8
Increased
11
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

EVO Hedge Fund Activity: Q3 2025 in Review

37 of the 7,664 institutional investors tracked by Wall St. Rank reported a position in Evotec (EVO) for Q3 2025, worth a combined $35.9M — down 12% from $40.5M a quarter earlier.

Fund positioning in EVO was balanced in Q3 2025: 8 funds opened new positions, 8 closed out, 11 added to existing stakes and 8 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $852K. The largest seller was Pitcairn, cutting an estimated $378K.

  • 37 institutional investors held Evotec (EVO) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $35.9M of Evotec stock for Q3 2025, down 12% quarter-over-quarter.
  • 8 funds opened new Evotec positions in Q3 2025 and 8 closed out, a net change of 0 holders.
  • The largest Evotec buyer in Q3 2025 was Wellington Management Group, an estimated $852K added.
  • The largest Evotec seller in Q3 2025 was Pitcairn, an estimated $378K sold.

Based on aggregated 13F filings for Q3 2025.